Authors of various reports have analyzed the institu tional incidence and putative risk factors for shuntdepen dent hydrocephalus after SAH. [2] [3] [4] [5] [6] [7] [8] [9] [10] Owing to small num bers in the individual series, the impact of hydrocephalus on patient outcomes and the performance of these shunts over time have not been adequately studied. Using popu lation data derived from administrative databases, we an alyzed the incidence of shuntdependent hydrocephalus in patients with aSAH from Ontario between 1995 and 2005. We sought to confirm incidence estimates and po tential risk factors, while further examining the mortality, morbidity, and shunt failure rates over time.
Methods

Data Sources
The data for this study were derived exclusively from administrative databases maintained at the Institute for Clinical and Evaluative Sciences in Toronto, Ontario, Can ada. The CIHIDAD provided information regarding hos pital admissions and patient diagnosis (ICD-9 and ICD-10 codes). Procedure information was derived from the OHIP billing database, capturing the majority of health care pro cedures performed in Ontario. The provincial Registered Persons Database provided vital statistics including mor tality rates.
Study Design
The research protocol was approved by the Research Ethics Board at the University of Toronto. The primary study design was a retrospective cohort analyzing the time to the occurrence of chronic hydrocephalus among the population of patients with SAH undergoing repair of a ruptured aneurysm. The ICD9 and 10 codes for SAH (430 and I60) were used to select SAH admissions (in the CIHIDAD). Patients were included in the study if there was a concurrent OHIP billing for aneurysm repair. Exclusion criteria for the study included the following: patient age < 18 years; aneurysms related to another CNS pathological condition (arteriovenous malformation, trau ma, or presumed mycotic aneurysm); aneurysm repairs incorporating a vascular bypass procedure; and patients who underwent a separate aneurysm repair procedure within the preceding 2 years. The cohort was followed up for the occurrence of chronic hydrocephalus, defined as a ventricular shunt placement procedure (OHIP). Ad ditional outcomes included shunt failure defined as the occurrence of a shunt revision (OHIP), death (Registered Persons Database), and discharge to a rehabilitation in stitute (CIHIDAD). The study included patients who un derwent an initial aneurysm repair procedure between January 1, 1995, and September 30, 2004 . Followup con tinued through March 31, 2005, ensuring a minimum of 6 months of followup for all patients.
Various baseline characteristics were derived from the databases for analysis of their potential impact on the studied outcomes. These included patient factors, such as age, sex, and medical comorbidity (measured using the CCI modified by Deyo et al.; 8 CIHIDAD); clinical events and features of the initial hemorrhage including evacu ation of an associated intracranial hemorrhage (OHIP), acute hydrocephalus (defined as EVD insertion prior to aneurysm repair; OHIP), and poor clinical grade (defined as ventilation on admission; OHIP); aneurysm character istics, such as size > 2.5 mm and location in the posterior circulation (OHIP); and either surgical or endovascular treatment modality (surgical treatment was defined as the inclusion of a operative microscope code in the procedure billing; OHIP). The potential impact of a complicated course of acute hydrocephalus (defined as multiple EVD revisions) during the initial admission was also studied.
Statistical Analysis
All database manipulation and statistical analyses were conducted using SAS statistical software (version 9.2, SAS Institute). The hydrocephalus and mortality outcomes were analyzed in uni and multivariate Cox proportional hazards models. To account for clustering effects within treatment centers, the standard errors of the estimates were adjusted using the sandwich covariance estimator of Lin and Wei. 20 The appropriateness of the proportional hazards assumption was confirmed. Risk factors for shunt failure were also analyzed in a recurrent events Cox proportional hazards model. Survival curves were constructed using the KaplanMeier method. Discharge to a rehabilitation insti tution was analyzed using a chisquare test and multivari ate logistic regression. The rates of shunt placement at the respective institutions were compared using a chisquare test, and the potential impact of volume on this outcome was studied using linear regression. The LOS was com pared using the Student ttest.
Results
Application of the inclusion and exclusion criteria yield ed 3120 patients who received treatment for aSAH between January 1, 1995, and September 30, 2004 . Chronic hydro cephalus, defined as occurrence of a shunt insertion proce dure, developed in 585 patients (18.8%). The mean followup period for patients was 4.25 years (range 0-10.25 years). The survival curve indicating the time to shunt placement is shown in Fig. 1 . Half of the shunt placement procedures were completed within 17 days, and 90% were completed within 60 days postoperatively. The shunt placement rates varied significantly between different institutions, ranging from 11.0 to 45.4% (p < 0.0001) (Fig. 2 upper) . Of note, there was a significant relationship between higher institu tional volume of patients with aSAH treated and lower rates of shunt placement (p = 0.01) (Fig. 2 lower) .
Predictors of Shunt-Dependent Hydrocephalus
Baseline characteristics of patients with and without shuntdependent hydrocephalus after SAH are shown in Table 1 . Also shown is the impact of these potential pre dictors on the time to the development of shuntdependent hydrocephalus. The development of shuntdependent hy drocephalus was unrelated to patient sex. Age was a strong predictor of hydrocephalus, with a 2% per year of age in crease in risk. Medical comorbidity was associated with hydrocephalus in univariate but not multivariate analysis.
Acute hydrocephalus requiring preoperative EVD place ment was the most potent predictor of shuntdependent hydrocephalus. Almost half of the patients with acute hy drocephalus went on to require shunt placement ( Table  2) . Following acute hydrocephalus, requirement of ven tilatory support on admission was the strongest predic tor of hydrocephalus. Aneurysm location in the posterior circulation and aneurysm size > 2.5 cm were also associ ated with shuntdependent hydrocephalus on multivariate analysis. The effects of treatment modality and associ ated intracerebral hemorrhage did not reach statistical significance on multivariate analysis.
The impact of multiple EVD revisions is presented in Table 2 . The first revision of an EVD is associated with a slightly greater rate of chronic hydrocephalus compared with the risk associated with acute EVD placement. The occurrence of 2 or more revisions of the EVD, although relatively rare, was associated with chronic hydrocepha lus in the majority of those patients.
Clinical Outcomes Following Shunt-Dependent Hydrocephalus
The mortality rate in patients with shuntdependent hydrocephalus was 27.9% versus 24.9% in patients with out hydrocephalus. However, after adjusting for the cova riates, there was no increased risk of death in the hydro cephalic patient group (HR 1.04, p = 0.63). In contrast, after adjusting for the measured baseline covariates, hy drocephalus was associated with indicators of morbidity. Intensive care unit LOS was significantly prolonged in patients with shuntdependent hydrocephalus compared with those without (14 vs 5 days, respectively; p < 0.0001). Similarly, the overall LOS was 48 days in the hydro cephalic group compared with 21 days in the nonhydro cephalic group (p < 0.0001). Discharge to a rehabilitation institution was also increased in the hydrocephalic group (adjusted OR 1.41, p < 0.001).
Ventricular Shunt Failure in Patients With Chronic Hydrocephalus After aSAH
Taking the group of 585 patients who underwent place ment of a ventricular shunt, we further analyzed the failure rates of these shunts over time. Of these patients, 173 patients (29.6%) underwent a subsequent revision of their shunt. Of those patients, 74 (43%) underwent a sec ond revision, of whom 32 (43%) underwent a third revi sion, and of whom 21 (66%) underwent 4 or more revisions. The KaplanMeier survival curves for these shunt failures are shown in Fig. 3 . Initial shunt failure occurred within 14 days postoperatively in 50% of patients, and within 60 days postoperatively in 90% of patients. More than 98% of the failures occurred within 6 months. As indicated above, subsequent failures occurred more commonly but also more quickly (Fig. 3) . Shunt failure was not associated with an increase in mortality (adjusted HR 1.03, p = 0.85).
Predictors of shunt failure were analyzed using uni and multivariate Cox proportional hazards models allow ing for repeated events (Table 3) . Most patient character istics, including age, sex, and CCI score, did not predict shunt failure. Similarly, aneurysm size and intracerebral hemorrhage were not associated with shunt failure. In univariate analysis, there was a trend toward significance for acute hydrocephalus. This significance did not per sist in the multivariate analysis. There was a trend toward increased risk for patients who initially underwent ven tilation in the multivariate analysis. Aneurysm location in the posterior circulation was associated with a signifi cantly increased risk of failure, while surgical clipping was associated with a reduced risk of shunt failure.
Discussion
Chronic hydrocephalus, defined as ventricular shunt placement, occurred in 18.75% of patients in the current study. This estimate is in keeping with institutional reports in the literature in which shuntdependent hydrocephalus has been reported to range between 6 and 37% patients with SAH. 5, 6, 9, 10, 16, 18, 23, 28, 30 The variability in shunt failure rates observed in the literature was also reflected in the current analysis, with rates varying significantly between different institutions. Of note, the present study suggested a relationship between volume of cases handled by an in stitution and shunt placement. Hospitals treating a larger case volume of aSAH tended to have lower rates of shunt insertion. Whether this phenomenon is related to a more conservative approach by more experienced surgeons, a difference in case mix, or some other process of care is beyond the scope of the current analysis.
The present study identified a number of risk factors predicting shuntdependent hydrocephalus in patients af ter SAH. In multivariate analysis, presentation character istics-such as patient age, ventilation on admission, an eurysm size > 2.5 cm, aneurysm location in the posterior circulation, and acute hydrocephalus-were all significant predictors of chronic hydrocephalus. In a summary of the literature, de Oliveira et al. 5 have found that the specific factors identified may vary from study to study, but in general, patient age, female sex, aneurysm location, acute hydrocephalus, poor neurological condition, presence of intraventricular hemorrhage, and the amount of blood in the subarachnoid space have all been associated with an increased risk of shunt dependency.
In-hospital events also influence the development of shuntdependent hydrocephalus after aSAH. The duration of external drainage is often cited as an important factor. Patients requiring prolonged external ventricular drain age have a significantly increased risk of chronic hydro cephalus after SAH.
12,22 Although we could not directly measure the duration of drainage, our study did indicate that multiple EVD placements were associated with a similarly increased risk. The use of multiple EVDs im plies an increased drainage period, as prolonged need for drainage is a common indication for drain replacement. Drain replacement may additionally indicate infection, a potential contributor to shunt dependency.
The impact of aneurysm treatment modality remains one of the more controversial risk factors for hydrocephalus following SAH. Our study did not find any significant dif ference in shuntdependent hydrocephalus between those patients whose aneurysms were treated with clips versus coils. There was, however, a weak trend toward lower shunt placement rates with surgical clipping. De Oliveira et al. 5 performed a metaanalysis of 5 large series in the litera ture in which treatment modality and hydrocephalus rates were reported. When the data were combined, endovascu lar coiling of the ruptured aneurysm was associated with a small but significantly increased risk of shunt-dependent hydrocephalus. 5 It is important to note that none of these were randomized studies and heterogeneity was signifi cant. 5 Furthermore, only 1 of the studies found a significant difference in chronic hydrocephalus rates, with an excess among patients whose aneurysms were treated with coils. 9 These authors hypothesize that mechanical clot removal at the time of surgery might improve CSF dynamics, thereby preventing chronic hydrocephalus. However, given the lack of randomization and the significant heterogeneity among In addition to prevalence and risk factors, the current study also assessed the clinical impact of hydrocephalus on the population of patients with aSAH. The mortal ity rate was higher among patients with hydrocephalus, although this difference did not reach statistical signifi cance in the multivariate survival analysis. In contrast, there appears to be an increased morbidity rate associated with hydrocephalus. Surrogate measures of morbidity, in cluding intensive care unit LOS, overall LOS, and dis charge to a rehabilitation institution, were all significantly increased in hydrocephalic patients. The clinical impact on morbidity and mortality rates is rarely commented on in the literature related to hydrocephalus after SAH. Demirgil et al. 7 also found no significant increase in mor tality for shuntdependent patients postSAH. Akyuz and Tuncer 1 found that shuntdependent hydrocephalus pre dicts poorer clinical outcome as measured on the Glas gow Outcome Scale. However, the majority of studieslikely owing to their retrospective nature-do not include clinical outcome data.
5,6,9,10
In most settings there is a steady attrition of ventricular shunt function over time. 4, 17 As imperfect mechanical de vices, shunts are prone to infection, catheter blockage, frac ture, disconnection, and valve failure. Such failures typi cally result in a return of hydrocephalusrelated symptoms necessitating shunt revision. In a randomized trial of pedi atric hydrocephalus in which 3 different shunt designs were compared, Kestle et al. 17 reported an overall shunt survival of 62, 52, 46, and 41% at 1, 2, 3, and 4 years, respectively. Borgbjerg et al. 4 compared VP and ventriculoatrial shunts in a randomized study of adult and pediatric patients. They found that overall shunt durability was 57% at 1 year and only 37% at 5 years. In contrast, only 30% of the shunts placed in the current analysis resulted in presentation for revision. Furthermore, with a mean followup of 4.25 years (range 6 months-10 years) shunt failure was exceedingly rare beyond 6 months after the ictus. It seems unlikely that the shunt hardware is performing better in this clinical set ting. Rather, these findings imply that shunt dependency after SAH may be a transient phenomenon in a substantial subset of patients. Cerebrospinal fluid pathways are clearly compromised in patients requiring shunting after SAH. It seems, however, that in a large group of patients these path ways resume functioning to such a point that mechanical shunt failures beyond 6 months remain asymptomatic.
Unfortunately, when the shunt does fail, many of these patients develop a more permanent and chronic hydrocephalus. Although the followup is less for sub sequent revisions, failure rates in this subset approach those observed in other forms of hydrocephalus. The pathophysiology of this phenomenon cannot by gleaned from the data presented here. It is possible that the impact of a failure causes further damage to the CNS pathways, contributing to extended shunt dependency. Alternatively, damage to CSF pathways likely exists along a continuum. The group of patients with severe and permanent disrup tion will be the group in whom shunt failures manifest.
While many strong predictors of shuntdependent hydrocephalus after SAH were identified in this study, predicting shunt failure from baseline SAH variables was less successful. Acute hydrocephalus, the most potent predictor of chronic hydrocephalus, was not associated with subsequent shunt failure. Other important predictors of shunt placement, such as age and aneurysm size, were similarly unrelated to shunt failure. Interestingly, initial clipping of the ruptured aneurysm appeared to protect against shunt failure in patients with hydrocephalus. This is despite the fact that surgery was only weakly associ ated with reduced rates of hydrocephalus in the primary analysis. It is possible that surgery protects against only a subset of failureprone hydrocephalic patients. In this manner, its benefit is less evident when analyzing the larg er population of patients with hydrocephalus after SAH. Another consideration is the direct effect of the coil ma terial on the risk of hydrocephalus. Polymercoated coils, for example, have been associated with hydrocephalus, even in the treatment of unruptured aneurysms; 3 this may result in delayed shunt dependency.
These findings have important clinical implications for the management of hydrocephalus following aSAH. Individual center data demonstrated that conservative shunt insertion is possible. If shunt dependency is transient and limited to a small subset, temporizing asymptomatic or minimally symptomatic patients may avoid the need for shunt insertion. Lumbar drainage and serial lumbar puncture can assist in temporizing mildly symptomatic individuals. 13 Strategies such as cisternal thrombolysis and fenestration of the lamina terminalis may augment CSF circulation during the perioperative period, until the native circulation can resume function. Combining these strategies with a conservative approach may realize the benefits of a reduced number of shunt placements.
The use of administrative data for clinical research has some important limitations. First, the diagnosis codes used in the analysis may not accurately reflect the proce dures and diagnoses in this population of patients. The OHIP database has been validated for other clinical sce narios and has demonstrated good accuracy and reliabil ity for procedural codes. 11 Similarly, codes for SAH have been validated in studies of stroke incidence and show very high sensitivity, specificity, and positive predictive values. 19, 26 Nevertheless, some of the codes used in this study have not been formally validated. We are, however, reassured that the prevalence of hydrocephalus and the relevant covariates, as well as their clinical impact, are concordant with series in the literature. A second limi tation of administrative data is the use of surrogates to estimate clinical outcomes. A procedure to place a ven tricular shunt is an appropriate surrogate for chronic hy drocephalus, denoting hydrocephalus of sufficient sever ity to warrant treatment. However, there remains a degree of subjectivity in this measure, as the threshold for shunt placement will vary between practitioners. While the mortality rate is a useful and reliable measure, surrogates of morbidity such as LOS and discharge to a rehabilita tion institution are less so. Importantly, these do not de scribe the specific impact on patient function and quality of life. Finally, in administrative data analysis the detail of the confounders will not be as sophisticated as in clini cal studies or may be unmeasured. Factors such as the amount of blood on the presenting scan, the actual size of the ventricles, and nuances of aneurysm morphology and clinical severity are not captured, resulting in a potential bias.
Conclusions
Using administrative data, we were able to analyze the incidence and risk factors for shuntdependent hy drocephalus after aSAH. More importantly, owing to the large numbers and lengthy followup afforded by these databases, we were able to study shunt failures in greater detail than authors of previous studies in the literature. Shunt failure occurred less frequently than seen in other forms of hydrocephalus. Moreover, initial shunt failures were limited to a relatively short interval after insertion, suggesting that shunt dependency may be a transient phenomenon in a large subset of patients. These findings have important implications for the management of hy drocephalus in patients with SAH. If shunt dependency is truly transient, a conservative approach-temporizing patients-may avoid the risk associated with shunt inser tion. Further studies with detailed clinical data are needed to confirm our findings and to better determine patients most at risk for longterm shunt dependency.
